Paying it forward? What’s that altruistic behaviour about and why might it be good for companies to encourage? Paying it forward is paying for the next person and people are more generous when they do that. Pay what you want, another model, can also be used by sustainable companies. The more we think, the more likely we are to indulge ourselves in more dessert. When we feel good about ourselves we’re more likely to indulge. There’s long been thought to be a genetic influence on how much alcohol people drink. Now there’s some proof. There’s a gene that regulates alcohol consumption in mice, just isolated at Newcastle Uni in the UK.
A new analysis of 50 studies finds that thinking before you eat can actually undermine your dieting goals. When we think, we often simply come up with reasons why we deserve that extra piece of pumpkin pie.
UK researchers have discovered a gene that regulates alcohol consumption and when faulty can cause excessive drinking. They have also identified the mechanism underlying this phenomenon.
Researchers found that shoppers spend more money when engaged in a chain of goodwill known as “Pay-it-forward” than when they can name their own price.
If oxytocin is administered to men and if they are shown pictures of their partner, the bonding hormone stimulates the reward center in the brain, increasing the attractiveness of the partner, and strengthening monogamy.
Archaeologists working in Nepal have uncovered evidence of a structure at the birthplace of the Buddha dating to the sixth century B.C.
The more women there are on a corporate board the less a company pays for its acquisitions, according to a new study
Although PCBs have been banned in the United States since 1979, University of Montreal and CHU Sainte-Justine researcher Maryse Bouchard has found that higher levels of the toxin was associated with lower cognitive performance in seniors.
It's never too late to get physically active, with even those starting relatively late in life reaping significant health benefits, finds research published online in the British Journal of Sports Medicine.
Eight of 16 patients participating in a study of an experimental immune system therapy directed against the most aggressive malignant brain tumors – glioblastoma multiforme – survived longer than five years after diagnosis